- Home
- RCKT vs MCR Comparison
RCKT vs MCR Comparison
Compare RCKT & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- MCR
- Stock Information
- Founded
- RCKT 1999
- MCR 1989
- Country
- RCKT United States
- MCR United States
- Employees
- RCKT N/A
- MCR N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- MCR Trusts Except Educational Religious and Charitable
- Sector
- RCKT Health Care
- MCR Finance
- Exchange
- RCKT Nasdaq
- MCR Nasdaq
- Market Cap
- RCKT 328.6M
- MCR 265.5M
- IPO Year
- RCKT N/A
- MCR N/A
- Fundamental
- Price
- RCKT $3.19
- MCR $6.50
- Analyst Decision
- RCKT Buy
- MCR
- Analyst Count
- RCKT 13
- MCR 0
- Target Price
- RCKT $12.96
- MCR N/A
- AVG Volume (30 Days)
- RCKT 5.7M
- MCR 66.7K
- Earning Date
- RCKT 11-06-2025
- MCR 01-01-0001
- Dividend Yield
- RCKT N/A
- MCR 8.52%
- EPS Growth
- RCKT N/A
- MCR N/A
- EPS
- RCKT N/A
- MCR 0.38
- Revenue
- RCKT N/A
- MCR N/A
- Revenue This Year
- RCKT N/A
- MCR N/A
- Revenue Next Year
- RCKT $108.43
- MCR N/A
- P/E Ratio
- RCKT N/A
- MCR $16.61
- Revenue Growth
- RCKT N/A
- MCR N/A
- 52 Week Low
- RCKT $2.19
- MCR $5.63
- 52 Week High
- RCKT $22.01
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- RCKT 47.80
- MCR 53.94
- Support Level
- RCKT $3.09
- MCR $6.35
- Resistance Level
- RCKT $3.29
- MCR $6.43
- Average True Range (ATR)
- RCKT 0.16
- MCR 0.04
- MACD
- RCKT -0.02
- MCR -0.34
- Stochastic Oscillator
- RCKT 14.64
- MCR 99.54
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.